Literature DB >> 18506368

Identification of IRF6 gene variants in three families with Van der Woude syndrome.

Ene-Choo Tan1, Eileen Chew-Ping Lim, Shiao-Hui Yap, Seng-Teik Lee, Joanne Cheng, Yong-Chen Por, Vincent Yeow.   

Abstract

Van der Woude syndrome is the most common cause of syndromic orofacial clefting. It is characterised by the presence of lip pits, cleft lip and/or cleft palate. It is transmitted in an autosomal dominant manner, with high penetrance and variable expressivity. Several mutations in the interferon regulatory factor 6 (IRF6) gene have been found in VWS families, suggesting that this gene is the primary locus. We screened for mutations in this gene in three families in our population. There was a recurrent nonsense mutation within exon 9 of the gene for a Malay family consisting of five affected members with different presentations. We also found a co-segregating rare polymorphism which would result in a non-synonymous change 23 bases downstream of the nonsense mutation. This polymorphism was present in <1% of the Malay subjects screened, but was not found among the Chinese and Indians in our population. For another family, a 396C-->T mutation (R45W in the DNA-binding domain) was found in the proband, although the possibility of a genetic defect elsewhere could not be excluded because his mother and twin sister (both unaffected) also had this variant. In the third case with complete absence of family history, a de novo deletion spanning the whole IRF6 gene was detected in the child with VWS. This case of haploinsufficiency caused disruption of orofacial development but not other organ systems as the child has no other medical or developmental abnormalities despite the deletion of at least five other genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506368

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

Review 1.  Toward an orofacial gene regulatory network.

Authors:  Youssef A Kousa; Brian C Schutte
Journal:  Dev Dyn       Date:  2015-09-17       Impact factor: 3.780

2.  IRF6 mutation screening in non-syndromic orofacial clefting: analysis of 1521 families.

Authors:  E J Leslie; D C Koboldt; C J Kang; L Ma; J T Hecht; G L Wehby; K Christensen; A E Czeizel; F W-B Deleyiannis; R S Fulton; R K Wilson; T H Beaty; B C Schutte; J C Murray; M L Marazita
Journal:  Clin Genet       Date:  2015-10-01       Impact factor: 4.438

3.  Rapid functional analysis of computationally complex rare human IRF6 gene variants using a novel zebrafish model.

Authors:  Edward B Li; Dawn Truong; Shawn A Hallett; Kusumika Mukherjee; Brian C Schutte; Eric C Liao
Journal:  PLoS Genet       Date:  2017-09-25       Impact factor: 5.917

4.  Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndrome.

Authors:  Renata L L Ferreira de Lima; Sarah A Hoper; Michella Ghassibe; Margaret E Cooper; Nicholas K Rorick; Shinji Kondo; Lori Katz; Mary L Marazita; John Compton; Sherri Bale; Ute Hehr; Michael J Dixon; Sandra Daack-Hirsch; Odile Boute; Bénédicte Bayet; Nicole Revencu; Christine Verellen-Dumoulin; Miikka Vikkula; Antônio Richieri-Costa; Danilo Moretti-Ferreira; Jeffrey C Murray; Brian C Schutte
Journal:  Genet Med       Date:  2009-04       Impact factor: 8.822

5.  A combined targeted mutation analysis of IRF6 gene would be useful in the first screening of oral facial clefts.

Authors:  Yah-Huei Wu-Chou; Lun-Jou Lo; Kuo-Ting Philip Chen; Chun-Shin Frank Chang; Yu-Ray Chen
Journal:  BMC Med Genet       Date:  2013-03-20       Impact factor: 2.103

6.  De novo 2.3 Mb microdeletion of 1q32.2 involving the Van der Woude Syndrome locus.

Authors:  Ene-Choo Tan; Eileen Cp Lim; Seng-Teik Lee
Journal:  Mol Cytogenet       Date:  2013-08-06       Impact factor: 2.009

Review 7.  Non-random distribution of deleterious mutations in the DNA and protein-binding domains of IRF6 are associated with Van Der Woude syndrome.

Authors:  Azeez A Alade; Carmen J Buxo-Martinez; Peter A Mossey; Lord J J Gowans; Mekonen A Eshete; Wasiu L Adeyemo; Thirona Naicker; Waheed A Awotoye; Chinyere Adeleke; Tamara Busch; Ada M Toraño; Carolina A Bello; Mairim Soto; Marilyn Soto; Ricardo Ledesma; Myrellis Marquez; Jose F Cordero; Lydia M Lopez-Del Valle; Maria I Salcedo; Natalio Debs; Mary Li; Aline Petrin; Joy Olotu; Colleen Aldous; James Olutayo; Modupe O Ogunlewe; Fekir Abate; Taye Hailu; Ibrahim Muhammed; Paul Gravem; Milliard Deribew; Mulualem Gesses; Mohaned Hassan; John Pape; Oluwole A Adeniyan; Solomon Obiri-Yeboah; Fareed K N Arthur; Alexander A Oti; Olubukola Olatosi; Sara E Miller; Peter Donkor; Martine M Dunnwald; Mary L Marazita; Adebowale A Adeyemo; Jeffrey C Murray; Azeez Butali
Journal:  Mol Genet Genomic Med       Date:  2020-06-17       Impact factor: 2.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.